EIPG: Calls for consultation on GMP and the 1st webinar of 2020
EIPG aims to ensure that will influence the evolution of EU regulations and guidelines concerning standards of quality, safety and efficacy of medicinal products. EMA has drafted a reflection paper on the responsibilities and activities of Marketing Authorisation Holders with respect to the European Commission’s guide to GMP for medicines for human and veterinary use. The 1st EIPG webinar of 2020 was held on February entitled “The Role of the Body Clock in Drug Development, Efficacy and Toxicity”
